	Capitaux D'Emprunt		Date
AbbVie	USD 62.97B	12M	2025-09
Amgen	USD 50B	2.43B	2025-12
Anika Therapeutics	USD 0	0	2025-03
Arrowhead Research	USD 538.1M	323.22M	2025-12
AstraZeneca	USD 26.14B	19.58B	2025-12
BioCryst Pharmaceuticals	USD 194.37M	48.43M	2025-09
Biogen	USD 6.29B	1.4M	2025-09
Bristol-Myers Squibb	USD 42.85B	1.62B	2025-12
Enanta Pharmaceuticals	USD 0	0	2024-12
Gilead Sciences	USD 22.14B	5M	2025-09
GlaxoSmithKline	GBP 14.71B	186M	2025-12
Halozyme Therapeutics	USD 2.14B	1.34B	2025-12
Heron Therapeutics	USD 149.65M	157K	2024-09
Immunic	USD 0	0	2024-06
Incyte	USD 30.2M	5.17M	2025-12
Insmed	USD 540.96M	1.24M	2025-12
Ionis Pharmaceuticals	USD 1.9B	1.87B	2025-12
J&J	USD 39.44B	30M	2025-12
Karyopharm Therapeutics	USD -0.93	0.67	2024-12
Ligand Pharmaceuticals	USD 445.49M	445.44M	2025-09
Merck	USD 39.97B	6B	2025-09
Neurocrine Biosciences	USD 169.5M	500K	2023-03
Novartis	USD 24.24B	174M	2025-09
Novavax	USD 223.63M	187K	2024-09
Pfizer	USD 57.41B	93M	2025-09
PTC Therapeutics	USD 2.03B	193.22M	2025-12
Roche Holding	CHF 27.43B	966M	2025-12
Sarepta Therapeutics	USD 828.97M	206.17M	2025-12
Vertex Pharmaceuticals	USD 111.4M	1.4M	2025-03

Enanta Pharmaceuticals Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.